MR Angiography and Imaging for the Evaluation of Middle Cerebral Artery Atherosclerotic Disease

References

1. 1.↵
   World Health Organization. Causes of Death. Geneva, Switzerland: World Health Organization; 2004. http://www.who.int/healthinfo/global_burden_disease/GBD_report_2004update_part2.pdf. Accessed September 15, 2011.
2. 2.↵
   1. Sridharan SE,
   2. Unnikrishnan JP,
   3. Sukumaran S,
   4. et al

   . Incidence, types, risk factors, and outcome of stroke in a developing country: the Trivandrum Stroke Registry. Stroke 2009; 40: 1212– 18

   Abstract/FREE Full Text
3. 3.↵
   1. Arenillas JF

   . Intracranial atherosclerosis: current concepts. Stroke 2011; 42 (1 suppl): S20– 23

   Abstract/FREE Full Text
4. 4.↵
   1. Lhermitte F,
   2. Gautier JC,
   3. Derouesne C,
   4. et al

   . Ischemic accidents in the middle cerebral artery territory: a study of the causes in 122 cases. Arch Neurol 1968; 19: 248– 56

   CrossRefPubMedWeb of Science
5. 5.↵
   1. Suwanwela NC,
   2. Chutinetr A

   . Risk factors for atherosclerosis of cervicocerebral arteries: intracranial versus extracranial. Neuroepidemiology 2003; 22: 37– 40

   CrossRefPubMed
6. 6.↵
   1. Wardlaw JM,
   2. Doubal FN,
   3. Eadie E,
   4. et al

   . Little association between intracranial arterial stenosis and lacunar stroke. Cerebrovasc Dis 2011; 31: 12– 18

   CrossRefPubMed
7. 7.↵
   1. Klein IF,
   2. Labreuche J,
   3. Lavallee PC,
   4. et al

   . Is moderate atherosclerotic stenosis in the middle cerebral artery a cause of or a coincidental finding in ischemic stroke? Cerebrovasc Dis 2010; 29: 140– 45

   CrossRefPubMedWeb of Science
8. 8.↵
   1. Mazighi M,
   2. Labreuche J,
   3. Gongora-Rivera F,
   4. et al

   . Autopsy prevalence of intracranial atherosclerosis in patients with fatal stroke. Stroke 2008; 39: 1142– 47

   Abstract/FREE Full Text
9. 9.↵
   1. Wong LK

   . Global burden of intracranial atherosclerosis. Int J Stroke 2006; 1: 158– 59

   CrossRefPubMedWeb of Science
10. 10.↵
    1. Mead GE,
    2. Lewis SC,
    3. Wardlaw JM,
    4. et al

    . Severe ipsilateral carotid stenosis and middle cerebral artery disease in lacunar ischaemic stroke: innocent bystanders? J Neurol 2002; 249: 266– 71

    CrossRefPubMedWeb of Science
11. 11.↵
    1. Rajapakse A,
    2. Rajapakse S,
    3. Sharma JC

    . Is investigating for carotid artery disease warranted in non-cortical lacunar infarction? Stroke 2011; 42: 217– 20

    Abstract/FREE Full Text
12. 12.↵
    1. Lyrer PA,
    2. Engelter S,
    3. Radu EW,
    4. et al

    . Cerebral infarcts related to isolated middle cerebral artery stenosis. Stroke 1997; 28: 1022– 27

    Abstract/FREE Full Text
13. 13.↵
    1. Bang OY,
    2. Heo JH,
    3. Kim JY,
    4. et al

    . Middle cerebral artery stenosis is a major clinical determinant in striatocapsular small, deep infarction. Arch Neurol 2002; 59: 259– 63

    CrossRefPubMedWeb of Science
14. 14.↵
    1. Adams HP Jr.,
    2. Bendixen BH,
    3. Kappelle LJ,
    4. et al

    . Classification of subtype of acute ischemic stroke: definitions for use in a multicenter clinical trial—TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993; 24: 35– 41
15. 15.↵
    1. Gongora-Rivera F,
    2. Labreuche J,
    3. Jaramillo A,
    4. et al

    . Autopsy prevalence of coronary atherosclerosis in patients with fatal stroke. Stroke 2007; 38: 1203– 10

    Abstract/FREE Full Text
16. 16.↵
    1. Lee PH,
    2. Oh SH,
    3. Bang OY,
    4. et al

    . Isolated middle cerebral artery disease: clinical and neuroradiological features depending on the pathogenesis. J Neurol Neurosurg Psychiatry 2004; 75: 727– 32

    Abstract/FREE Full Text
17. 17.↵
    1. Chen XY,
    2. Wong KS,
    3. Lam WW,
    4. et al

    . Middle cerebral artery atherosclerosis: histological comparison between plaques associated with and not associated with infarct in a postmortem study. Cerebrovasc Dis 2008; 25: 74– 80

    CrossRefPubMedWeb of Science
18. 18.↵
    1. Lee PH,
    2. Oh SH,
    3. Bang OY,
    4. et al

    . Infarct patterns in atherosclerotic middle cerebral artery versus internal carotid artery disease. Neurology 2004; 62: 1291– 96

    Abstract/FREE Full Text
19. 19.↵
    1. Bonati LH,
    2. Wetzel SG,
    3. Gandjour J,
    4. et al

    . Diffusion-weighted imaging in stroke attributable to internal carotid artery dissection: the significance of vessel patency. Stroke 2008; 39: 483– 85

    Abstract/FREE Full Text
20. 20.↵
    1. Kim YD,
    2. Choi HY,
    3. Cho HJ,
    4. et al

    . Increasing frequency and burden of cerebral artery atherosclerosis in Korean stroke patients. Yonsei Med J 2010; 51: 318– 25

    CrossRefPubMed
21. 21.↵
    1. Liu HM,
    2. Tu YK,
    3. Yip PK,
    4. et al

    . Evaluation of intracranial and extracranial carotid steno-occlusive diseases in Taiwan Chinese patients with MR angiography: preliminary experience. Stroke 1996; 27: 650– 53

    Abstract/FREE Full Text
22. 22.↵
    1. Wong KS,
    2. Huang YN,
    3. Gao S,
    4. et al

    . Intracranial stenosis in Chinese patients with acute stroke. Neurology 1998; 50: 812– 13

    Abstract/FREE Full Text
23. 23.↵
    1. Wong KS,
    2. Ng PW,
    3. Tang A,
    4. et al

    . Prevalence of asymptomatic intracranial atherosclerosis in high-risk patients. Neurology 2007; 68: 2035– 38

    Abstract/FREE Full Text
24. 24.↵
    1. Kasner SE,
    2. Chimowitz MI,
    3. Lynn MJ,
    4. et al

    . Predictors of ischemic stroke in the territory of a symptomatic intracranial arterial stenosis. Circulation 2006; 113: 555– 63

    Abstract/FREE Full Text
25. 25.↵
    1. Kern R,
    2. Steinke W,
    3. Daffertshofer M,
    4. et al

    . Stroke recurrences in patients with symptomatic vs asymptomatic middle cerebral artery disease. Neurology 2005; 65: 859– 64

    Abstract/FREE Full Text
26. 26.↵
    1. Famakin BM,
    2. Chimowitz MI,
    3. Lynn MJ,
    4. et al

    . Causes and severity of ischemic stroke in patients with symptomatic intracranial arterial stenosis. Stroke 2009; 40: 1999– 2003

    Abstract/FREE Full Text
27. 27.↵
    1. Akins PT,
    2. Pilgram TK,
    3. Cross DT 3rd.,
    4. et al

    . Natural history of stenosis from intracranial atherosclerosis by serial angiography. Stroke 1998; 29: 433– 38

    Abstract/FREE Full Text
28. 28.↵
    1. Block F,
    2. Hoang PA

    . Oral anticoagulation in symptomatic intracranial stenoses [in German]. Nervenarzt 2003; 74: 523– 26. Epub 2003 May 10

    PubMed
29. 29.↵
    1. Chimowitz MI,
    2. Kokkinos J,
    3. Strong J,
    4. et al

    . The Warfarin-Aspirin Symptomatic Intracranial Disease Study. Neurology 1995; 45: 1488– 93

    Abstract/FREE Full Text
30. 30.↵
    1. Kremer C,
    2. Schaettin T,
    3. Georgiadis D,
    4. et al

    . Prognosis of asymptomatic stenosis of the middle cerebral artery. J Neurol Neurosurg Psychiatry 2004; 75: 1300– 03

    Abstract/FREE Full Text
31. 31.↵
    1. Thijs VN,
    2. Albers GW

    . Symptomatic intracranial atherosclerosis: outcome of patients who fail antithrombotic therapy. Neurology 2000; 55: 490– 97

    Abstract/FREE Full Text
32. 32.↵
    1. Thomas GN,
    2. Chen XY,
    3. Lin JW,
    4. et al

    . Middle cerebral artery stenosis increased the risk of vascular disease mortality among type 2 diabetic patients. Cerebrovasc Dis 2008; 25: 261– 67

    CrossRefPubMed
33. 33.↵
    1. Turan TN,
    2. Derdeyn CP,
    3. Fiorella D,
    4. et al

    . Treatment of atherosclerotic intracranial arterial stenosis. Stroke 2009; 40: 2257– 61

    FREE Full Text
34. 34.↵
    1. Gupta R,
    2. Schumacher HC,
    3. Mangla S,
    4. et al

    . Urgent endovascular revascularization for symptomatic intracranial atherosclerotic stenosis. Neurology 2003; 61: 1729– 35

    Abstract/FREE Full Text
35. 35.↵
    1. Marks MP,
    2. Marcellus M,
    3. Norbash AM,
    4. et al

    . Outcome of angioplasty for atherosclerotic intracranial stenosis. Stroke 1999; 30: 1065– 69

    Abstract/FREE Full Text
36. 36.↵
    1. Marks MP,
    2. Marcellus ML,
    3. Do HM,
    4. et al

    . Intracranial angioplasty without stenting for symptomatic atherosclerotic stenosis: long-term follow-up. AJNR Am J Neuroradiol 2005; 26: 525– 30

    Abstract/FREE Full Text
37. 37.↵
    1. Yoon W,
    2. Seo JJ,
    3. Cho KH,
    4. et al

    . Symptomatic middle cerebral artery stenosis treated with intracranial angioplasty: experience in 32 patients. Radiology 2005; 237: 620– 26

    PubMedWeb of Science
38. 38.↵
    1. Leung TW,
    2. Yu SC,
    3. Lam WW,
    4. et al

    . Would self-expanding stent occlude middle cerebral artery perforators? Stroke 2009; 40: 1910– 12

    Abstract/FREE Full Text
39. 39.↵
    1. Siddiq F,
    2. Vazquez G,
    3. Memon MZ,
    4. et al

    . Comparison of primary angioplasty with stent placement for treating symptomatic intracranial atherosclerotic diseases: a multicenter study. Stroke 2008; 39: 2505– 10

    Abstract/FREE Full Text
40. 40.↵
    1. Suh DC,
    2. Kim JK,
    3. Choi JW,
    4. et al

    . Intracranial stenting of severe symptomatic intracranial stenosis: results of 100 consecutive patients. AJNR Am J Neuroradiol 2008; 29: 781– 85

    Abstract/FREE Full Text
41. 41.↵
    1. Gröschel K,
    2. Schnaudigel S,
    3. Pilgram SM,
    4. et al

    . A systematic review on outcome after stenting for intracranial atherosclerosis. Stroke 2009; 40: e340– 47

    Abstract/FREE Full Text
42. 42.↵
    1. Tsai ST,
    2. Yen PS,
    3. Wang YJ,
    4. et al

    . Superficial temporal artery-middle cerebral artery bypass for ischemic atherosclerotic middle cerebral artery disease. J Clin Neurosci 2009; 16: 1013– 17

    CrossRefPubMed
43. 43.↵
    1. O JH,
    2. Jang KS,
    3. Yoo Ie R,
    4. et al

    . Assessment of cerebrovascular reserve before and after STA-MCA bypass surgery by SPECT and SPM analysis. Korean J Radiol 2007; 8: 458– 65

    CrossRefPubMed
44. 44.↵
    1. Gao S,
    2. Lam WW,
    3. Chan YL,
    4. et al

    . Optimal values of flow velocity on transcranial Doppler in grading middle cerebral artery stenosis in comparison with magnetic resonance angiography. J Neuroimaging 2002; 12: 213– 18

    CrossRefPubMed
45. 45.↵
    1. Navarro JC,
    2. Lao AY,
    3. Sharma VK,
    4. et al

    . The accuracy of transcranial Doppler in the diagnosis of middle cerebral artery stenosis. Cerebrovasc Dis 2007; 23: 325– 30

    CrossRefPubMed
46. 46.↵
    1. Kaps M,
    2. Stolz E,
    3. Allendoerfer J

    . Prognostic value of transcranial sonography in acute stroke patients. Eur Neurol 2008; 59 (suppl 1): 9– 16

    CrossRefPubMed
47. 47.↵
    1. Lien LM,
    2. Chen WH,
    3. Chen JR,
    4. et al

    . Comparison of transcranial color-coded sonography and magnetic resonance angiography in acute ischemic stroke. J Neuroimaging 2001; 11: 363– 68

    CrossRefPubMed
48. 48.↵
    1. Heiserman JE,
    2. Drayer BP,
    3. Keller PJ,
    4. et al

    . Intracranial vascular stenosis and occlusion: evaluation with three-dimensional time-of-flight MR angiography. Radiology 1992; 185: 667– 73

    PubMedWeb of Science
49. 49.↵
    1. Sawada M,
    2. Yano H,
    3. Shinoda J,
    4. et al

    . Symptomatic middle cerebral artery stenosis and occlusion: comparison of three-dimensional time-of-flight magnetic resonance angiography with conventional angiography. Neurol Med Chir (Tokyo) 1994; 34: 682– 85

    CrossRefPubMed
50. 50.↵
    1. Korogi Y,
    2. Takahashi M,
    3. Mabuchi N,
    4. et al

    . Intracranial vascular stenosis and occlusion: diagnostic accuracy of three-dimensional, Fourier transform, time-of-flight MR angiography. Radiology 1994; 193: 187– 93

    PubMedWeb of Science
51. 51.↵
    1. Stock KW,
    2. Radue EW,
    3. Jacob AL,
    4. et al

    . Intracranial arteries: prospective blinded comparative study of MR angiography and DSA in 50 patients. Radiology 1995; 195: 451– 56

    PubMedWeb of Science
52. 52.↵
    1. Korogi Y,
    2. Takahashi M,
    3. Nakagawa T,
    4. et al

    . Intracranial vascular stenosis and occlusion: MR angiographic findings. AJNR Am J Neuroradiol 1997; 18: 135– 43

    Abstract
53. 53.↵
    1. Hirai T,
    2. Korogi Y,
    3. Ono K,
    4. et al

    . Prospective evaluation of suspected stenoocclusive disease of the intracranial artery: combined MR angiography and CT angiography compared with digital subtraction angiography. AJNR Am J Neuroradiol 2002; 23: 93– 101

    Abstract/FREE Full Text
54. 54.↵
    1. Bash S,
    2. Villablanca JP,
    3. Jahan R,
    4. et al

    . Intracranial vascular stenosis and occlusive disease: evaluation with CT angiography, MR angiography, and digital subtraction angiography. AJNR Am J Neuroradiol 2005; 26: 1012– 21

    Abstract/FREE Full Text
55. 55.↵
    1. Wong KS,
    2. Lam WW,
    3. Liang E,
    4. et al

    . Variability of magnetic resonance angiography and computed tomography angiography in grading middle cerebral artery stenosis. Stroke 1996; 27: 1084– 87

    Abstract/FREE Full Text
56. 56.↵
    1. Willinek WA,
    2. Born M,
    3. Simon B,
    4. et al

    . Time-of-flight MR angiography: comparison of 3.0-T imaging and 1.5-T imaging–initial experience. Radiology 2003; 229: 913– 20

    CrossRefPubMedWeb of Science
57. 57.↵
    1. Willinek WA,
    2. Gieseke J,
    3. von Falkenhausen M,
    4. et al

    . Sensitivity encoding (SENSE) for high spatial resolution time-of-flight MR angiography of the intracranial arteries at 3.0 T. Rofo 2004; 176: 21– 26

    PubMed
58. 58.↵
    1. Choi CG,
    2. Lee DH,
    3. Lee JH,
    4. et al

    . Detection of intracranial atherosclerotic steno-occlusive disease with 3D time-of-flight magnetic resonance angiography with sensitivity encoding at 3T. AJNR Am J Neuroradiol 2007; 28: 439– 46

    Abstract/FREE Full Text
59. 59.↵
    1. Furst G,
    2. Hofer M,
    3. Sitzer M,
    4. et al

    . Factors influencing flow-induced signal loss in MR angiography: an in vitro study. J Comput Assist Tomogr 1995; 19: 692– 99

    PubMed
60. 60.↵
    1. Nederkoorn PJ,
    2. van der Graaf Y,
    3. Eikelboom BC,
    4. et al

    . Time-of-flight MR angiography of carotid artery stenosis: does a flow void represent severe stenosis? AJNR Am J Neuroradiol 2002; 23: 1779– 84

    Abstract/FREE Full Text
61. 61.↵
    1. Man BL,
    2. Fu YP,
    3. Chan YY,
    4. et al

    . Use of magnetic resonance angiography to predict long-term outcomes of ischemic stroke patients with concurrent stenoses in Hong Kong. Cerebrovasc Dis 2009; 28: 112– 18

    CrossRefPubMed
62. 62.↵
    1. Suzuki T,
    2. Ogasawara K,
    3. Hirooka R,
    4. et al

    . Preoperative single-slab 3D time-of-flight magnetic resonance angiography predicts development of new cerebral ischemic events after carotid endarterectomy: clinical article. J Neurosurg 2009; 111: 141– 46

    CrossRefPubMed
63. 63.↵
    1. Miyazawa N,
    2. Akiyama I,
    3. Yamagata Z

    . Analysis of incidence and risk factors for progression in patients with intracranial steno-occlusive lesions by serial magnetic resonance angiography. Clin Neurol Neurosurg 2007; 109: 680– 85

    CrossRefPubMed
64. 64.↵
    1. Kwon SU,
    2. Cho YJ,
    3. Koo JS,
    4. et al

    . Cilostazol prevents the progression of the symptomatic intracranial arterial stenosis: the multicenter double-blind placebo-controlled trial of cilostazol in symptomatic intracranial arterial stenosis. Stroke 2005; 36: 782– 86. Epub 2005 Mar 3

    Abstract/FREE Full Text
65. 65.↵
    1. Mok VC,
    2. Lam WW,
    3. Chen XY,
    4. et al

    . Statins for asymptomatic middle cerebral artery stenosis: the Regression of Cerebral Artery Stenosis study. Cerebrovasc Dis 2009; 28: 18– 25

    CrossRefPubMed
66. 66.↵
    1. Prabhakaran S,
    2. Wells KR,
    3. Jhaveri MD,
    4. et al

    . Hemodynamic changes following Wingspan stent placement: a quantitative magnetic resonance angiography study. J Neuroimaging 2011; 21: e109– 13. Epub 2009 Jan 22

    CrossRefPubMed
67. 67.↵
    1. Prabhakaran S,
    2. Warrior L,
    3. Wells KR,
    4. et al

    . The utility of quantitative magnetic resonance angiography in the assessment of intracranial in-stent stenosis. Stroke 2009; 40: 991– 93. Epub 2009 Jan 22

    Abstract/FREE Full Text
68. 68.↵
    1. Wasserman BA,
    2. Wityk RJ,
    3. Trout HH 3rd.,
    4. et al

    . Low-grade carotid stenosis: looking beyond the lumen with MRI. Stroke 2005; 36: 2504– 13

    Abstract/FREE Full Text
69. 69.↵
    1. Glagov S,
    2. Weisenberg E,
    3. Zarins CK,
    4. et al

    . Compensatory enlargement of human atherosclerotic coronary arteries. N Engl J Med 1987; 316: 1371– 75

    CrossRefPubMedWeb of Science
70. 70.↵
    1. Niizuma K,
    2. Shimizu H,
    3. Takada S,
    4. et al

    . Middle cerebral artery plaque imaging using 3-Tesla high-resolution MRI. J Clin Neurosci 2008; 15: 1137– 41

    CrossRefPubMedWeb of Science
71. 71.↵
    1. Xu WH,
    2. Li ML,
    3. Gao S,
    4. et al

    . In vivo high-resolution MR imaging of symptomatic and asymptomatic middle cerebral artery atherosclerotic stenosis. Atherosclerosis 2010; 212: 507– 11

    CrossRefPubMedWeb of Science
72. 72.↵
    1. Samuels OB,
    2. Joseph GJ,
    3. Lynn MJ,
    4. et al

    . A standardized method for measuring intracranial arterial stenosis. AJNR Am J Neuroradiol 2000; 21: 643– 46

    Abstract/FREE Full Text
73. 73.↵
    1. Klein IF,
    2. Lavallee PC,
    3. Touboul PJ,
    4. et al

    . In vivo middle cerebral artery plaque imaging by high-resolution MRI. Neurology 2006; 25 67: 327–29
74. 74.↵
    1. Park JK,
    2. Kim SH,
    3. Kim BS,
    4. et al

    . Imaging of intracranial plaques with black-blood double inversion recovery MR imaging and CT. J Neuroimaging 2011; 21: e64– 68

    CrossRefPubMed
75. 75.↵
    1. Markl M,
    2. Uhl M,
    3. Wieben O,
    4. et al

    . High-resolution 3T MRI for the assessment of cervical and superficial cranial arteries in giant cell arteritis. J Magn Reson Imaging 2006; 24: 423– 27

    CrossRefPubMedWeb of Science
76. 76.↵
    1. Turan TN,
    2. Bonilha L,
    3. Morgan PS,
    4. et al

    . Intraplaque hemorrhage in symptomatic intracranial atherosclerotic disease. J Neuroimaging 2011; 21: e159– 61

    CrossRefPubMedWeb of Science
77. 77.↵
    1. Li ML,
    2. Xu WH,
    3. Song L,
    4. et al

    . Atherosclerosis of middle cerebral artery: evaluation with high-resolution MR imaging at 3T. Atherosclerosis 2009; 204: 447– 52

    CrossRefPubMedWeb of Science
78. 78.↵
    1. Saam T,
    2. Cai J,
    3. Ma L,
    4. et al

    . Comparison of symptomatic and asymptomatic atherosclerotic carotid plaque features with in vivo MR imaging. Radiology 2006; 240: 464– 72

    CrossRefPubMedWeb of Science
79. 79.↵
    1. Swartz RH,
    2. Bhuta SS,
    3. Farb RI,
    4. et al

    . Intracranial arterial wall imaging using high-resolution 3-Tesla contrast-enhanced MRI. Neurology 2009; 72: 627– 34

    Abstract/FREE Full Text
80. 80.↵
    1. Hirai T,
    2. Korogi Y,
    3. Murata Y,
    4. et al

    . Intracranial artery dissections: serial evaluation with MR imaging, MR angiography, and source images of MR angiography. Radiat Med 2003; 21: 86– 93

    PubMed
81. 81.↵
    1. Buhk JH,
    2. Ries T,
    3. Finck-Wedel AK,
    4. et al

    . Possibilities and limitations in imaging the intracranial arteries in the context of a contrast-enhanced whole-body magnetic resonance angiographic screening protocol at 1.5 versus 3 Tesla. J Comput Assist Tomog 2011; 35: 4– 8

    CrossRefPubMed
82. 82.↵
    1. Jahnke C,
    2. Dietrich T,
    3. Paetsch I,
    4. et al

    . Experimental evaluation of the detectability of submillimeter atherosclerotic lesions in ex vivo human iliac arteries with ultrahigh-field (7.0 T) magnetic resonance imaging. Int J Cardiovasc Imaging 2007; 23: 519– 27

    CrossRefPubMed
83. 83.↵
    1. Kim YD,
    2. Choi HY,
    3. Jung YH,
    4. et al

    . Mirror pattern of cerebral artery atherosclerosis in patients with ischaemic stroke. Eur J Neurol 2009; 16: 1159– 64

    CrossRefPubMed
84. 84.↵
    1. Yuan C,
    2. Mitsumori LM,
    3. Ferguson MS,
    4. et al

    . In vivo accuracy of multispectral magnetic resonance imaging for identifying lipid-rich necrotic cores and intraplaque hemorrhage in advanced human carotid plaques. Circulation 2001; 104: 2051– 56

    Abstract/FREE Full Text
85. 85.↵
    1. Watanabe Y,
    2. Nagayama M

    . MR plaque imaging of the carotid artery. Neuroradiology 2010; 52: 253– 74

    CrossRefPubMed
86. 86.↵
    1. McAteer MA,
    2. Akhtar AM,
    3. von Zur Muhlen C,
    4. et al

    . An approach to molecular imaging of atherosclerosis, thrombosis, and vascular inflammation using microparticles of iron oxide. Atherosclerosis 2010; 209: 18– 27

    CrossRefPubMedWeb of Science
87. 87.↵
    1. Kerwin WS,
    2. O'Brien KD,
    3. Ferguson MS,
    4. et al

    . Inflammation in carotid atherosclerotic plaque: a dynamic contrast-enhanced MR imaging study. Radiology 2006; 241: 459– 68

    CrossRefPubMedWeb of Science
88. 88.↵
    1. Lopez-Cancio E,
    2. Dorado L,
    3. Millan M,
    4. et al

    . The population-based Barcelona-Asymptomatic Intracranial Atherosclerosis Study (ASIA): rationale and design. BMC Neurol 2011; 11: 22
89. 89.↵
    1. Honda M,
    2. Kawahara I,
    3. Kitagawa N,
    4. et al

    . Asymptomatic carotid artery plaques: use of magnetic resonance imaging to characterize vulnerable plaques in 6 cases. Surg Neurol 2007; 67: 35– 39

    CrossRefPubMed
90. 90.↵
    1. Saam T,
    2. Cai JM,
    3. Cai YQ,
    4. et al

    . Carotid plaque composition differs between ethno-racial groups: an MRI pilot study comparing mainland Chinese and American Caucasian patients. Arterioscler Thromb Vasc Biol 2005; 25: 611– 16

    Abstract/FREE Full Text
91. 91.↵
    1. Yuan C,
    2. Kerwin WS,
    3. Ferguson MS,
    4. et al

    . Contrast-enhanced high resolution MRI for atherosclerotic carotid artery tissue characterization. J Magn Reson Imaging 2002; 15: 62– 67

    CrossRefPubMedWeb of Science